Entering the era of highly effective CFTR modulator therapy
Author:
Funder
Cystic Fibrosis Foundation
Foundation for the National Institutes of Health
Vertex Pharmaceuticals
Publisher
Elsevier BV
Subject
General Medicine
Reference9 articles.
1. Cystic fibrosis;Elborn;Lancet,2016
2. A systematic review of the clinical efficacy and safety of CFTR modulators in cystic fibrosis;Habib;Sci Rep,2019
3. Rapid therapeutic advances in CFTR modulator science;Clancy;Pediatr Pulmonol,2018
4. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial;Heijerman;Lancet,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators;International Journal of Molecular Sciences;2023-03-05
2. The psychological implications and health risks of cystic fibrosis pre- and post- CFTR modulator therapy;Chronic Illness;2022-05-03
3. Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF);American Journal of Respiratory and Critical Care Medicine;2022-02-01
4. Pulmonary gene delivery—Realities and possibilities;Experimental Biology and Medicine;2020-11-12
5. Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions;ERJ Open Research;2020-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3